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ABSTRACT: A dissymmetrically substituted orthogonal
BODIPY dimer and an orthogonal BODIPY trimer exist as
two stable conformers, which are in fact atropisomeric
enantiomers. The racemic mixture can be separated by
HPLC using a chiral stationary phase. These enantiomeric
derivatives hold great potential as chiral agents in asymmetric
synthesis, ﬂuorogenic/chromogenic sensing, and biological
applications.
BODIPY dyes, once considered to be yet another class ofﬂuorophores with applications limited to laser dyes and
biological labeling, continue to ﬂourish as their rich chemistry1
unravels and a multitude of new potential applications keep
pouring in.2 It is remarkable that all positions on the parent
boradiazaindacene ring including the boron bridge can be
functionalized using straightforward procedures, resulting in a
large family of chromophores with an impressive diversity of
photophysical and photochemical properties. Case in point, the
parent compound has a very small intersystem crossing rate,3
but on heavy atom functionalization of the 3,5-positions,
BODIPY derivatives are transformed into eﬀective singlet
oxygen generators with potential in photodynamic therapy.4
In our attempts to ﬁnd an alternative to the heavy atom
substitution protocol, we discovered that orthogonal BODIPY
dimers have a remarkable excited state feature, which makes
them very eﬃcient in intersystem crossing.5
The dimer (3, Scheme 1) is locked at a particular
conformation due to a double methyl−methyl clash, and
both single crystal X-ray diﬀraction studies (Figure 1) and
computational studies5 conﬁrmed this particular structure.
At that point, we recognized the potential of this compound
for atropisomerism. Axial chirality in atropisomeric compounds
is the result of a nonplanar arrangement of diﬀerent groups on
both sides of the chiral plane, and enantiopure products can be
isolated because of the restricted rotation of a single bond on
that chiral axis. Most extensively used and studied atropiso-
meric molecules are binaphthyl derivatives with various
applications.6 On the other hand, chiral BODIPY derivatives
were also previously reported;7 in a few, chirality is generated
by the tethered chiral prosthetic groups,7 and in one recent
example, it is generated by the asymmetrically substituted
boron bridge.8 Nevertheless, chirality based on rotationally
hindered BODIPY cores was not previously proposed or
explored.
In the case of dimer 3, there is still a symmetry plane;
however, a single dissymmetric substitution would remove that.
To carry out that operation chemically, we formylated dimer 3.
The reaction takes place essentially exclusively in the meso-
functionalized ring. To further increase the complexity, we
wanted to generate another BODIPY unit, where the formyl
carbon would then supply the meso-carbon for the nascent third
BODIPY ring. The latter reaction was carried out following
highly established procedures for BODIPY synthesis while the
pyrrole rings were supplied by 2,4-dimethylpyrrole (Scheme 1).
It should be also noted here that the formyl group is a highly
useful precursor for other functionalities. For both the formyl
derivative 4 and the trimer 5, puriﬁcation (as the racemic
mixture) was through silica gel chromatography using dichloro-
methane/methanol (95%/5%) and only dichloromethane as
the eluent solvents, respectively. The racemates were then
subjected to chiral HPLC puriﬁcation. The conditions had to
be carefully optimized to aﬀect eﬃcient separation of both
enantiomeric couples.
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Analytical and preparative HPLC separations of racemic
mixtures of compounds 4 and 5 were performed using cellulose
based Chiralcel-OD columns. For analytical and preparative
resolutions, a racemic mixture of the compounds was dissolved
in an isocratic eluent of isopropyl alcohol or ethanol/heptane,
ﬁltered, and injected to the column.
HPLC chromatograms are shown in Figure 2. Racemic
compound 4 yielded easily resolvable peaks under these
conditions, but the resolution for 5 was somewhat more
challenging. Separated enantiomers were checked for their
mass/NMR/optical spectra (see Supporting Information) and
were found to be identical as expected.
Circular dichroism data (Figures 3 and 4) clearly
demonstrate successful separation of the two enantiomers.
While the racemic mixture 4 resulted in an essentially ﬂat line
indicative of achirality, enantiomer 4a and the enantiomer 4b
show the mirror image spectra. The same is true for 5, 5a, and
5b. The peaks in the visible region are related to the sharp S0−
S1 transition of the BODIPY core.
Compound 4 has a major absorption band in the visible
region (λmax = 505 nm, ε = 78 000 M
−1 cm−1). Only weak
ﬂuorescence emission (quantum yield <1%) is observed with a
peak at 520 nm. The trimer, on the other hand, has a stronger
absorption at 514 nm (ε = 162 000 M−1 cm−1). This compound
also has a low quantum yield of emission (quantum yield <1%)
(Figure 5, Table 1).
The low quantum yields are to be expected based on our
earlier work5a,b suggesting unusual excited state conﬁgurations
leading to fast intersystem crossing. In summary, we present the
ﬁrst example of atropisomeric BODIPY derivatives with
persistent chirality due to multiple methyl group clashes. The
orthogonally linked BODIPY compounds have been demon-
strated to have interesting photophysical properties, but now,
we show that they can be isolated as atropisomeric chiral
Scheme 1. Synthesis of the Atropisomeric BODIPY
Derivative 4 and 5a
aAs expected, 4 and 5 are produced as racemates. For both 4 and 5,
(R) enantiomers are depicted.
Figure 1. Single crystal X-ray diﬀraction structure of the orthogonal
dimer 3 (50% probability level).5a Dihedral angle between the two
BODIPY cores is 89.4°.
Figure 2. HPLC separation of compound 4 to 4a (20.3 min) and 4b
(33.4 min) (95%/5%, heptane/IPA, detection @270 nm) (top) and
compound 5 to 5a (18.5 min) and 5b (20.6 min) (98%/2%, heptane/
ethanol, detection @510 nm) (bottom).
Figure 3. Circular dichroism spectra of racemic mixture 4 and the two
enantiomers following resolution using Chiralcel-OD columns via
preparative HPLC. The structures shown on the ﬁgure are the energy
minimized structures (Supporting Information), and the assignment is
arbitrary.
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compounds. Their large extinction coeﬃcients and large
anisotropy factors (g > 5 × 10−3) would mean that similar
compounds may ﬁnd practical applications as chiroptical
ﬂuorogenic/chromogenic sensors, and as highly selective chiral
photosensitizers in a therapeutic context, among other potential
ﬁelds. Our work along that line is in progress.
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Figure 4. Circular dichroism spectra of racemic mixture 5 and the two
enantiomers following resolution using Chiralcel-OD columns via
preparative HPLC. The structures shown on the ﬁgure are the energy
minimized structures (Supporting Information), and the assignment is
arbitrary.
Figure 5. Electronic absorption (solid line) and emission (dashed line)
spectra of compounds 4 and 5. Emission quantum yield is very low.
Table 1. Photophysical Characterization of Compounds 4
and 5
dye λabs
a/nm εmax/M
−1 cm−1 λems
a/nm Φfb τfa/ns
4 505 78 000 520 0.0078 3.14
5 514 162 000 528 0.0075 3.72
aData acquired in CH2Cl2.
bIn reference to ﬂuorescein in 0.1 M
NaOH solution, excited at 495 nm.
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